5225965458844/5/2024 1:30:55 PM4/5/2024 1:30:55 PMSurgery for Mesothelioma After Radiation Therapy Using Exquisite Systemic Therapy Histologically proven mesothelioma 16 Previously untreated mesothelioma 17 STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx1230https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{A614246A-90E8-4D83-B034-A9F5A647AF1A}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
5223836267104/5/2024 1:32:12 PM4/5/2024 1:32:12 PMA Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With MSI-H CRC, esophagogastric cancer, mesothelioma, and HNSCC, all naïve to anti-PD(L)1 STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx440https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{8E065694-8D88-4568-A874-E71AA1C68B7D}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
5223775488954/5/2024 1:32:25 PM4/5/2024 1:32:25 PMA Phase 1 Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors Pancreatic Cancer - Mesothelioma - A pre-treatment STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx1030https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{3E857B23-A933-4843-88B2-D14A314CA839}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
5224201186514/5/2024 1:24:17 PM4/5/2024 1:24:17 PMAn Open-label, Multicenter, Dose Escalation Phase 1b Study to Assess the Safety and MTC), gastroesophageal cancer (GEC), mesothelioma, breast cancer (BC) and STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx6330https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{E5E39B7D-F663-406C-8667-A63A1EF8C899}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
5221294704514/5/2024 1:16:34 PM4/5/2024 1:16:34 PMA Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects Small Cell Lung Carcinoma - Mesothelioma - Thyroid Carcinoma STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx1630https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{77B66B7F-ECE0-44EA-8CA9-38B3299B558E}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242
5221806335244/5/2024 1:18:49 PM4/5/2024 1:18:49 PMA Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab for Participants With Advanced Solid Tumors STS_ListItem_GenericListhttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx440https://www.uhn.caFalsehttps://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research{B871C8A9-618E-4F05-A3EE-BFB649E66A62}~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js4242

~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js

Last reviewed:
Last modified: 6/15/2021 11:04 AM
Back to Top